Phenominer Database Results (26 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
MWF-Chr 8SHR/Rkb systolic blood pressure control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. arterial blood pressure trait male 84 days 10 155.9 mmHg 1.9 6.01 tail cuff plethysmography 0.0 0 109288 3141
MWF-Chr 8SHR/Rkb single kidney wet weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass male 168 days 10 5.66 g/kg 0.09 0.28 post excision weight measurement kidney 0.0 0 108930 3133
MWF-Chr 8SHR/Rkb single kidney wet weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass female 168 days 10 5.72 g/kg 0.08 0.25 post excision weight measurement kidney 0.0 0 108931 3133
MWF-Chr 8SHR/Rkb heart left ventricle weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass male 168 days 10 2.0 mg/g 0.04 0.13 post excision weight measurement heart left ventricle 0.0 0 108942 3133
MWF-Chr 8SHR/Rkb heart left ventricle weight to body weight ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass female 168 days 10 2.49 mg/g 0.05 0.16 post excision weight measurement heart left ventricle 0.0 0 108943 3133
MWF-Chr 8SHR/Rkb serum creatinine level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood creatinine amount female 168 days 10 0.48 mg/dl 0.01 0.04 serum creatinine analysis 0.0 0 108949 3133
MWF-Chr 8SHR/Rkb serum urea nitrogen level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood urea nitrogen amount female 168 days 10 26.3 mg/dl 0.62 1.95 serum urea analysis 0.0 0 108960 3133
MWF-Chr 8SHR/Rkb kidney fibrotic lesion area to total kidney area ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney integrity trait female 168 days 10 3.3 % 0.1 0.32 ex vivo light microscopy with digital image analysis kidney 0.0 0 108983 3133
MWF-Chr 8SHR/Rkb body weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. body mass male 168 days 20 351.1 g 6.8 30.41 body weighing method 0.0 0 108918 3133
MWF-Chr 8SHR/Rkb creatinine clearance control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. glomerular filtration trait female 168 days 10 0.0 ml/min 0.0 0.0 serum creatinine analysis 0.0 0 108955 3133
MWF-Chr 8SHR/Rkb serum urea nitrogen level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood urea nitrogen amount male 168 days 10 30.28 mg/dl 1.09 3.45 serum urea analysis 0.0 0 108961 3133
MWF-Chr 8SHR/Rkb urine albumin excretion rate control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. urine albumin amount male 56 days 20 2.6 mg/d 0.6 2.68 enzyme linked immunosorbent assay 0.0 0 108964 3133
MWF-Chr 8SHR/Rkb urine albumin excretion rate control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. urine albumin amount male 126 days-224 days 10 20.0 mg/d 0.0 0.0 enzyme linked immunosorbent assay 0.0 0 108967 3133
MWF-Chr 8SHR/Rkb negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84 days 10 7.7 null 0.1 0.32 wire myography 0.0 0 logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) 109385 3141
MWF-Chr 8SHR/Rkb single kidney wet weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass male 168 days 10 1.99 g 0.04 0.13 post excision weight measurement kidney 0.0 0 108924 3133
MWF-Chr 8SHR/Rkb heart left ventricle weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass female 168 days 10 0.5 g 0.01 0.03 post excision weight measurement heart left ventricle 0.0 0 108937 3133
MWF-Chr 8SHR/Rkb creatinine clearance control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. glomerular filtration trait male 168 days 10 0.0 ml/min 0.0 0.0 serum creatinine analysis 0.0 0 108954 3133
MWF-Chr 8SHR/Rkb urine albumin excretion rate control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. urine albumin amount female 56 days 20 0.4 mg/d 0.1 0.45 enzyme linked immunosorbent assay 0.0 0 108968 3133
MWF-Chr 8SHR/Rkb kidney glomerulus count control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney glomerulus quantity male 28 days 7 N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 23771.0 null 1352.0 3577.06 ex vivo light microscopy with digital image analysis 0.0 0 108971 3133
MWF-Chr 8SHR/Rkb acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasodilation trait male 84 days 10 83.4 % 7.0 22.14 wire myography 0.0 0 109370 3141
MWF-Chr 8SHR/Rkb body weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. body mass female 168 days 20 204.4 g 2.4 10.73 body weighing method 0.0 0 108919 3133
MWF-Chr 8SHR/Rkb heart left ventricle weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. heart left ventricle mass male 168 days 10 0.7 g 0.02 0.06 post excision weight measurement heart left ventricle 0.0 0 108936 3133
MWF-Chr 8SHR/Rkb norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL control condition Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84 days 10 87.2 % 18.0 56.92 wire myography 0.0 0 norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) 109380 3141
MWF-Chr 8SHR/Rkb single kidney wet weight control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney mass female 168 days 10 1.17 g 0.02 0.06 post excision weight measurement kidney 0.0 0 108925 3133
MWF-Chr 8SHR/Rkb serum creatinine level control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. blood creatinine amount male 168 days 10 0.44 mg/dl 0.01 0.05 serum creatinine analysis 0.0 0 108948 3133
MWF-Chr 8SHR/Rkb kidney fibrotic lesion area to total kidney area ratio control condition Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. kidney integrity trait male 168 days 10 7.5 % 0.3 0.95 ex vivo light microscopy with digital image analysis kidney 0.0 0 108982 3133